Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Long Acting Amylin Receptor Agonists And Uses Thereof
Abstract: The present disclosure relates to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity and/or chronic weight management, dyslipidemia and/or NASH. The disclosure relates to compounds that agonize the amylin receptor and can lower food intake, body weight, glucose and/or triglycerides, so can be used to treat diabetes, obesity, and/or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
30 September 2023
Publication Number
36/2024
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
Indianapolis, Indiana 46285
Inventors
1. ABRAHAM, Milata Mary
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
2. BRIERE, Daniel Anthony
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
3. GUO, Lili
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
4. KEYSER, Samantha Grace Lyons
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
5. LEE, John
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
6. QU, Hongchang
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202317065967-STATEMENT OF UNDERTAKING (FORM 3) [30-09-2023(online)].pdf | 2023-09-30 |
| 2 | 202317065967-Sequence Listing in txt [30-09-2023(online)].txt | 2023-09-30 |
| 3 | 202317065967-Sequence Listing in PDF [30-09-2023(online)].pdf | 2023-09-30 |
| 4 | 202317065967-PROOF OF RIGHT [30-09-2023(online)].pdf | 2023-09-30 |
| 5 | 202317065967-FORM 1 [30-09-2023(online)].pdf | 2023-09-30 |
| 6 | 202317065967-DECLARATION OF INVENTORSHIP (FORM 5) [30-09-2023(online)].pdf | 2023-09-30 |
| 7 | 202317065967-COMPLETE SPECIFICATION [30-09-2023(online)].pdf | 2023-09-30 |
| 8 | 202317065967-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [30-09-2023(online)].pdf | 2023-09-30 |
| 9 | 202317065967-MARKED COPIES OF AMENDEMENTS [02-11-2023(online)].pdf | 2023-11-02 |
| 10 | 202317065967-FORM 13 [02-11-2023(online)].pdf | 2023-11-02 |
| 11 | 202317065967-AMMENDED DOCUMENTS [02-11-2023(online)].pdf | 2023-11-02 |
| 12 | 202317065967-FORM 18 [03-11-2023(online)].pdf | 2023-11-03 |
| 13 | 202317065967-FORM-26 [21-11-2023(online)].pdf | 2023-11-21 |
| 14 | 202317065967-Information under section 8(2) [07-03-2024(online)].pdf | 2024-03-07 |
| 15 | 202317065967-FORM 3 [07-03-2024(online)].pdf | 2024-03-07 |